Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis.
Tappe
D
D
Institute of Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany. dtappe@hygiene.uni-wuerzburg.de
Müller
A
A
Frosch
M
M
Stich
A
A
D000666:Amphotericin B / Q000627:therapeutic use*; D000871:Anthelmintics / Q000627:therapeutic use*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D004444:Echinococcosis, Hepatic / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009574:Nitro Compounds; D013844:Thiazoles / Q000627:therapeutic use*; D017211:Treatment Failure
D000871:Anthelmintics; D009574:Nitro Compounds; D013844:Thiazoles; D000666:Amphotericin B; C041747:nitazoxanide